Literature DB >> 19394490

Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.

Varant Kupelian1, Kevin T McVary, Michael J Barry, Carol L Link, Raymond C Rosen, Lalitha Padmanabhan Aiyer, Patrick Mollon, John B McKinlay.   

Abstract

OBJECTIVES: To determine whether an association exists between C-reactive protein (CRP) levels and lower urinary tract symptoms (LUTS) as assessed by the American Urological Association Symptom Index (AUA-SI) among both men and women, and to determine the association of CRP levels with the individual urologic symptoms comprising the AUA-SI among both men and women.
METHODS: The Boston Area Community Health survey used a multistage stratified design to recruit a random sample of 5502 adults aged 30-79 years. Blood samples were obtained from 3752 participants. The analyses were conducted on 1898 men and 1854 women with complete data on CRP levels. Overall LUTS was defined as an AUA-SI of >or=8 (moderate to severe LUTS). The urologic symptoms comprising the AUA-SI were included in the analysis as reports of fairly often to almost always vs non/rarely/a few times.
RESULTS: A statistically significant association was observed between the CRP levels and overall LUTS among both men and women. The pattern of associations between the individual symptoms and CRP levels varied by sex. Nocturia and straining were associated with greater CRP levels among men, and incomplete emptying and weak stream were associated with greater CRP levels among women.
CONCLUSIONS: The results of this study have demonstrated an association between CRP levels and LUTS in both men and women. The dose-response relationship between increased CRP levels and an increased odds of LUTS supports the hypothesized role of inflammatory processes in the etiology of LUTS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394490      PMCID: PMC3551271          DOI: 10.1016/j.urology.2008.12.012

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  27 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.

Authors:  J C Nickel; J Downey; I Young; S Boag
Journal:  BJU Int       Date:  1999-12       Impact factor: 5.588

4.  Manual for scoring socioeconomic status for research on health behavior.

Authors:  L W Green
Journal:  Public Health Rep       Date:  1970-09       Impact factor: 2.792

5.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

Authors:  Garry Welch; Katie Weinger; Michael J Barry
Journal:  Urology       Date:  2002-02       Impact factor: 2.649

6.  The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.

Authors:  P Boyle; C Robertson; C Mazzetta; M Keech; F D R Hobbs; R Fourcade; L Kiemeney; C Lee
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

7.  The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

Authors:  J Curtis Nickel; Claus G Roehrborn; Michael P O'Leary; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

8.  Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

Authors:  Michael A Joseph; Sioban D Harlow; John T Wei; Aruna V Sarma; Rodney L Dunn; Jeremy M G Taylor; Sherman A James; Kathleen A Cooney; Kay M Doerr; James E Montie; David Schottenfeld
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

9.  Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

10.  Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.

Authors:  Franco Di Silverio; Vincenzo Gentile; Anna De Matteis; Gianna Mariotti; Voria Giuseppe; Pastore Antonio Luigi; Alessandro Sciarra
Journal:  Eur Urol       Date:  2003-02       Impact factor: 20.096

View more
  29 in total

1.  Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men.

Authors:  Sean A Martin; Matthew T Haren; Villis R Marshall; Kylie Lange; Gary A Wittert
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

2.  Non steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men.

Authors:  Margaret A Gates; Andre B Araujo; Susan A Hall; Gary A Wittert; John B McKinlay
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

3.  Female voiding dysfunction: prevalence and common associations.

Authors:  Bernard T Haylen
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

4.  The role of serum C-reactive protein in women with lower urinary tract symptoms.

Authors:  Sheng-Mou Hsiao; Ho-Hsiung Lin; Hann-Chorng Kuo
Journal:  Int Urogynecol J       Date:  2012-03-16       Impact factor: 2.894

5.  Biomarkers Implicated in Lower Urinary Tract Symptoms: Systematic Review and Pathway Analyses.

Authors:  Nazema Y Siddiqui; Brian T Helfand; Victor P Andreev; Joseph T Kowalski; Megan S Bradley; H Henry Lai; Mitchell B Berger; Margaret G Mueller; Jennifer A Bickhaus; Vignesh T Packiam; Dee Fenner; Brenda W Gillispie; Ziya Kirkali
Journal:  J Urol       Date:  2019-10-09       Impact factor: 7.450

6.  Intakes of vitamins and minerals in relation to urinary incontinence, voiding, and storage symptoms in women: a cross-sectional analysis from the Boston Area Community Health survey.

Authors:  Nancy N Maserejian; Edward L Giovannucci; Kevin T McVary; John B McKinlay
Journal:  Eur Urol       Date:  2011-03-15       Impact factor: 20.096

7.  Dietary macronutrient and energy intake and urinary incontinence in women.

Authors:  Nancy N Maserejian; Edward L Giovannucci; Kevin T McVary; Catherine McGrother; John B McKinlay
Journal:  Am J Epidemiol       Date:  2010-04-25       Impact factor: 4.897

Review 8.  Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?

Authors:  Granville L Lloyd; Jeffrey M Marks; William A Ricke
Journal:  Curr Urol Rep       Date:  2019-08-03       Impact factor: 3.092

9.  Cohort profile: the Boston Area Community Health (BACH) survey.

Authors:  Rebecca S Piccolo; Andre B Araujo; Neil Pearce; John B McKinlay
Journal:  Int J Epidemiol       Date:  2012-12-05       Impact factor: 7.196

10.  Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study.

Authors:  Andre B Araujo; H Klar Yaggi; May Yang; Kevin T McVary; Shona C Fang; Donald L Bliwise
Journal:  J Urol       Date:  2013-07-15       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.